Jun 22, 2026 · 36 min
RFK Jr. targets SSRI overuse as deprescribing movement gains ground
R.F.K. Jr.’s Newest Mission: Getting Us Off Antidepressants
The debate over deprescribing highlights a critical gap in modern medicine, where starting a psychiatric drug is simple but safely stopping it remains a complex, unsupported journey.
- 1The deprescribing movement aims to safely taper patients off long-term psychiatric medications they may no longer need.
- 2HHS Secretary Robert F. Kennedy Jr. is proposing financial incentives and expert panels to curb SSRI overuse.
- 3Patients attempting to stop antidepressants face severe withdrawal symptoms like brain zaps and insomnia without proper medical supervision.
The brief
The growing deprescribing movement advocates for carefully tapering patients off long-term psychiatric medications, a process that is often physically and psychologically grueling for individuals trying to manage their mental health.
HHS Secretary Robert F. Kennedy Jr. is pushing to curb the overuse of SSRI antidepressants, proposing financial incentives for doctors who help patients taper off and establishing a technical panel to draft official guidelines.
While some medical experts welcome the focus on overprescribing, others in the American Psychiatric Association express caution, emphasizing the severe risks of DIY tapering and the lack of robust clinical support networks.
Patients attempting to stop their medications frequently report debilitating withdrawal symptoms, including insomnia and brain zaps, illustrating the medical community's struggle to guide patients back to a drug-free state.
Featuring
Mentioned
Robert F. Kennedy Jr.
Deprescribing psychiatric drugs
Selective serotonin reuptake inhibitor
insomniaListen to the full episode and explore every guest, topic, and moment on PodLume.